MR

Mark Rothera

Former President and CEO

Viracta Therapeutics

Roles

Former President and CEOatViracta Therapeutics
Chief Executive Officer & Board MemberatTreeFrog Therapeutics

Viracta Therapeutics Pipeline

DrugIndicationPhase
Nanatinostat + Valganciclovir (Nana-val)Relapsed/Refractory EBV+ Lymphomas (PTCL, CTCL, DLBCL)Phase 2